Two Sigma Advisers
DMAC icon

Two Sigma Advisers’s DiaMedica Therapeutics DMAC Stock Holding History

Two Sigma Advisers’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,900
Closed -$31K – 2555
2022
Q3 		$31K Sell
24,900
-1,800
-7% -$2.81K ﹤0.01% 2415
2022
Q2 		$54K Sell
26,700
-22,700
-46% -$53K ﹤0.01% 2468
2022
Q1 		$124K Sell
49,400
-57,200
-54% -$162K ﹤0.01% 2473
2021
Q4 		$398K Buy
106,600
+26,000
+32% +$102K ﹤0.01% 2024
2021
Q3 		$323K Buy
80,600
+67,800
+530% +$259K ﹤0.01% 2086
2021
Q2 		$57K Buy
12,800
+2,100
+20% +$17.2K ﹤0.01% 2375
2021
Q1 		$98K Buy
+10,700
New +$100K ﹤0.01% 2445

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Two Sigma Advisers's DMAC Position: Q4 2022 in Review

Two Sigma Advisers sold out of DiaMedica Therapeutics (DMAC) in Q4 2022, closing a stake of 24,900 shares — an estimated $31K sold.

Two Sigma Advisers first reported a position in DMAC in Q1 2021 and held it in 7 quarters. The position peaked at $398K in Q4 2021. 28 funds tracked by Wall St. Rank hold DMAC as of Q4 2022.

  • Two Sigma Advisers reported no remaining DiaMedica Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 24,900 DiaMedica Therapeutics shares in Q4 2022, an estimated $31K.
  • Two Sigma Advisers first reported a position in DiaMedica Therapeutics in Q1 2021 and held it in 7 quarters.
  • Two Sigma Advisers's DiaMedica Therapeutics position peaked at $398K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q4 2022.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.